Aims In men, the inflammatory response to intravenous endotoxin depresses apparent oral clearances of antipyrine, hexobarbitone, and theophylline. The aim of this study was to investigate whether there might be gender differences in the regulation of hepatic cytochromes P450. Methods Experiments were carried out in seven healthy women volunteers (ages 19-51, median 22 years). Each woman received a cocktail of the three drugs on two occassions, once after a saline injection and again after endotoxin. Results Endotoxin injections, but not saline, caused the expected physiologic responses of inflammation including fever and increases in circulating tumor necrosis factor-a, interleukin-6, and C-reactive protein. When compared with the saline control studies, endotoxin significantly decreased clearances of all probes: antipyrine, 31% (95%CI 21%-41%); hexobarbitone, 20% (95%CI 10-31%); and theophylline, 20% (95%CI 10%-30%). The decreases were comparable with those found in the men previously studied (35%, 27%, and 22%, respectively). Conclusions These data show that endotoxin-induced inflammation decreases hepatic cytochrome P450-mediated metabolism of selected probe drugs in women as it does in men.
Introduction drugs have been reported [(18-21) ]. Differences for the most part were small, most medications appeared to be TGram-negative bacterial sepsis is still a leading cause of death in the intensive care setting [1, 2] and both men and metabolized similarly in men and women, and a recent report [22] saw no gender differences in amounts of specific women are susceptible to the sequelae of sepsis. A preliminary study [3] of drugs given to these patients P450 proteins in samples of normal liver. However, whether there are important gender differences in the way inflamrevealed that a mean (±s.d.) of 12.1±3.9 systemically active xenobiotic drugs are administered during the period mation affects regulation of P450s has not yet been investigated. To address this question, the current study of sepsis. Animal models of sepsis using endotoxin (lipopolysaccharide or LPS) to elicit the inflammatory response [4] [5] [6] [7] [8] administered AP, HB, and TH drug probe cocktails to female volunteers and assessed the effects of two consecutive and administration of inflammatory cytokines such as interleukin-1, tumor necrosis factor, and interleukin-6 [7, LPS injections on expression of the acute phase response and on clearances of the drug probes. [9] [10] [11] [12] [13] [14] have demonstrated significant decreases in hepatic cytochrome P450-mediated drug metabolism. Therefore, it is likely that septic patients who have high levels of Methods inflammatory cytokine production have depressed hepatic
Nine female volunteers aged 21-51 years participated in P450 activities which could be clinically significant. Our this study. Two were excluded as explained below. The group recently addressed the question of whether inflamstudy was approved both by the University of Kentucky mation significantly depresses hepatic P450-mediated drug Institutional Review Board and the General Clinical metabolism in humans by studying affects of LPS adminisResearch Center. The protocol was identical to the tration in men [15] . The clearances of the probe drugs previously reported study using male volunteers [15] , except antipyrine (AP), hexobarbitone (HB), and theophylline that each clearance study was performed within the first 10 (TH), ingested as a 'cocktail' [16, 17] , were decreased by days (follicular phase) of each woman's menstrual cycle and 35%, 27%, and 22%, respectively, after the male volunteers immediately prior to each study a plasma b-HCG pregnancy received two consecutive doses of LPS. test was negative. At enrolment, women were deemed to be healthy by medical history, physical examination, blood theophylline products, non-steroidal anti-inflammatory P450-mediated drug metabolism' with inflammation.) However, after studying three more women, the subject drugs or other medications for at least 3 days prior to the study.
with the increases was the only one noted to have any increases in clearances after LPS injections. and LPS) were analyzed by two-tailed paired t-tests using standard techniques [29] . Confidence intervals for the 48 h after the drug cocktail for plasma drug concentrations and at various time points for plasma TNFa, IL-6, and changes in clearances were determined at the 95% level. Changes in peak serum cytokines, peak serum acute phase serum C-reactive protein determinations. Blood samples for complete blood count and clinical chemistry screens were proteins, bilirubin, albumin, white blood cell count, liver enzymes, temperature, and heart rate, were analyzed by collected 48 h after the second dose of LPS for comparison with baseline samples collected at enrolment. paired Student's t-test. The relationship between alterations in clearances caused by LPS with changes in plasma TNF, Plasma concentrations of the cytokines tumor necrosis factor-a (TNF), and interleukin-6 (IL-6) were determplasma IL-6 and serum C-reactive proteins were correlated to assess a statistical association using regression analysis and ined by commercial kits (Quantikine, R&D Systems, Minneapolis, MN.) and the acute phase reactant C-reactive F-test. Statistical significance was defined as P<0.05 for all tests. protein (C-RP) was determined in serum using nephelometry [23] . The TNF, IL-6, and C-reactive protein data were published recently in another report [24] combined with Results the results from the men volunteers [15] . Plasma AP, HB, and TH were analyzed as described previously [25] .
LPS administration to the women subjects caused the expected physical signs consistent with inflammation. Each AP, HB, and TH plasma concentration vs time data for each clearance study were analyzed by a non-linear least woman reported onset of chills, headache, malaise, and very mild nausea beginning after approximately 1 h and lasting squares regression analysis program (R-STRIPA, Micromath Scientific Software, Salt Lake City, Utah). Area under the approximately 2 h. Statistically significant ( P<0.05) peak elevations in temperature from 97.8±0.1 to 100.4±0.2°F concentration-time curve (AUC) was calculated by the trapezoidal rule from 0 to the last time point and then and pulse rates from 62±3 to 85±6 beats min −1 were seen 2.5 h after the first LPS injection with similar responses after extrapolated to infinity using the following formula: C last /l z where C last is the last measured concentration time point the second LPS dose. No such symptoms or physical signs were seen after the saline injection. The LPS did not lead and l z is the terminal elimination rate constant obtained from R-STRIP. Apparent oral clearance (CL o ) of drug was to changes in platelet counts (314±53 to 280±40 X10 3 /ml), liver alanine aminotransferase (18±2 to 15±2 iu l −1 ), defined as: CL o =ORAL DOSE/AUC and calculated as such. In all cases, the extrapolated AUC (C last /z) represented alkaline phosphatase (58±4 to 52±3 iu l −1 ), or total bilirubin (0.7±0.2 to 0.4±0.1 mg 100 ml −1 ) when these less than 20% of the total AUC utilized in the calculations of CL o .
parameters were assessed 48 h after the second LPS dose and compared with baseline values obtained at recruitment. However there were minor but significant ( P<0.05) Statistical analysis changes in white blood cell count (5.8±0.5 to 5.2±0.1 ×10 3 ml −1 ), haematocrit (39.6±1.1 to 34.9±0.6), and It was assumed that a 30% change in drug clearance would be clinically significant and a power analysis was performed albumin values (4.6±0.1 to 4.1±0.1 g 100 ml −1 ), probably related to the inflammatory process and/or the amount of using the known intraindividual coefficient of variation (6.8-8.2%) from previous clearance studies for antipyrine blood removed for the protocol. The expected changes in the plasma cytokines IL-6 and [26] and determined that an n=6 would be sufficient to detect this change. Although six women were initially TNF and the serum acute phase C-reactive protein were seen after each dose of LPS. A plasma TNF peak of enrolled, one subject refused the second dose of LPS and was excluded from analysis. Another subject had an 67.9±17.9 units ml −1 (mean±s.e. mean) occurred at 1.5 h after the first LPS dose and promptly returned to undetectable unexpected 55% increase in TH clearance and a 164% increase in HB clearance. (The inclusion of these subjects baseline concentrations by 4 h. A smaller peak of 28.3±9.3 occurred 1.5 h after the second dose of LPS. A plasma IL-6 in a preliminary report [27] led to the suggestion that women might have 'less inhibition than men of peak of 74.2±34.7 units ml −1 occurred at 1.5 h after the first LPS dose and remained elevated (67.1±11.4) at 4.5 h before returning to a baseline of 6-10 by 6.5 h. After the second LPS dose, a smaller IL-6 peak of 59.4±23.7 was seen at 1.5 h, remaining elevated (39.0±10.2) at 4.5 h, and returning to baseline by 6.5 h. Marked increases in C-reactive protein were seen from a baseline concentration of 0.14±0.04 mg 100 ml −1 to 2.80±0.63 at 24 h and 3.37±0.51 at 48 h. Figure 1 shows the changes in clearances for each of the three drug probes for each subject. In all except one subject, for each probe there was a decrease in clearance found after LPS. In one subject, there was no decrease in TH clearance (2.166 to 2.163 l h −1 ). The mean decrease in clearance for AP was 31% (95% confidence interval 21%-41%), for HB 20% (95% confidence interval 10%-31%), and for TH 20% (95% confidence interval 10%-30%). These decreases in clearances were all statistically significant. When changes in AP clearances for individual women were correlated with peak TNF and IL-6 plasma responses after the first LPS dose as an indication of the 'intensity' of the inflammatory response, there were only weak, non-statistically significant correlations found with r=0.71 for IL-6 and r=0.54 for TNF ( Figure 2 ).
Discussion
The above findings show that women volunteers have a similar response to administered endotoxin (LPS) as do men volunteers [15] with respect to decreases in activities of the hepatic cytochromes P450 responsible for the clearances of AP, HB, and TH. The 20%-30% changes seen probably underestimate what occurs in acutely ill septic patients who have a much more intense inflammatory response and multisystem organ failure. Because these studies were not prospectively designed to rule out gender differences in hepatic P450 responses to inflammation, it is possible that subtle differences may exist and might be more pronounced with clinically severe inflammation. However, since the findings in women are so much like those in men, it is likely that female septic patients are just as vulnerable to inhibition of hepatic P450-mediated drug metabolism as male patients. A limitation of the current study is that the clearances of the three drug probes reflect mainly activities of only some hepatic P450s; namely, CYP1A2 (AP and TH), CYP2C Nadin et al. [13] showed that TNF given to male rats and 1.44±0.22 l h −1 respectively, for hexobarbitone 19.8±2.9
depressed CYPs 2C11 and 3A2 mRNA and proteins, but potential clinical importance of these changes for septic patients who are likely to receive medications requiring metabolism by various P450 isoforms [3] , in vivo human Several recent reviews of the effects of gender on drug metabolism [18] [19] [20] [21] have concluded that there may be studies should be performed assessing inflammatory effects on activities of all the important P450s.
gender differences in humans, but that these differences and TH clearance decreases by about 30% from the beginning of the cycle (follicular phase) to the end of the cycle (luteal phase) [41] . The current study controlled for this variation by assessing women within the first 10 days of their cycle and none of the women were taking oral contraceptives. With regard to HB, a report [42] that young women cleared R-mephobarbitone much slower than young men (3.5-fold slower!) suggested significant gender differences in the activity of CYP2C19. However, 4/8 of the women were on oral contraceptives which might have depressed clearances, and 2/8 of the men smoked, which might have increased their clearances. Data from the current study suggest that control HB clearances in the women of 19.7±2.9 l h −1 (mean±s.e. mean) were not different from the HB clearances of the men (15.8±4.4 l h −1 ) in the earlier study [15] . The well known gender-related differences in P450 expression due to growth hormone were recently reviewed [21] . Certainly in rodents, expression of particular P450 isoforms such as the rat CYP2C11 (male) and 2C12 (female) are related to concentration profiles of plasma growth hormone. Whether any human P450 isoforms are so regulated is not known. Morgan's studies [43] suggest that inflammatory changes in P450s are probably independent of changes in growth hormone. In human volunteer studies, administration of LPS causes a prompt rise in growth hormone that peaks in 3h [44] . However, severely injured patients tend to have profound decreases in growth hormone [45] . Whether changes in growth hormone secretion during inflammation contributes to a gender-related difference in human P450 expression seems unlikely, but was not addressed in the current studies.
Some in vitro data suggest there may be gender-related differences in the inflammatory response [46] . However, the women subjects in the current study had the same clinical, cytokine, and acute phase protein responses as the men previously reported [15] . That there were also comparable decreases in drug probe clearances suggests that the intensity of the systemic and hepatic acute phase response correlates between extent of depression of AP clearance and the peak plasma concentrations (pg ml −1 ) or b) the peak tumor necrosis IL-6 and TNF responses probably reflects the small number factor-a (TNF) after the first dose of LPS in each subject. For IL-6, r=0.705 and for TNF r=0.538, neither of which were of subjects and variability of the cytokine measurements. statistically significant.
In conclusion, this study demonstrates that inflammation induced by gram-negative bacterial endotoxin causes depression of cytochrome P450-mediated drug metabolism must be subtle. George et al. [22] did not find genderrelated differences in concentrations of CYPs 1A2, 2C, 2E1, of the drug probes AP, HB, and TH in healthy women volunteers. Inflammatory depression of hepatic drug metaband 3A proteins in human livers. The effects of gender on clearances of drug probes similar to those used in the current olism does not appear to be affected by gender, at least for the P450 isoforms assessed by these drug probes, mainly study also have been reported [36] [37] [38] [39] [40] [41] [42] . No gender effects on clearance were seen for AP [36] , although oral CYPs 1A2 and 2C19. Similar studies should be performed in men and women using probes for other important contraceptive use depressed clearance. Studies using caffeine as a probe for 1A2 reported both decreased activity in P450 isoforms. nonsmoking women [37] and no gender difference [38] . Studies of TH metabolism, also reflecting primarily 1A2 This work was supported by the Department of Veterans Affairs and by an NIH General Clinical Research Center activity [29] , showed increased clearances in nonsmoking women [39] or no gender differences [40] . An explanation grant #M01RR02602-07. The authors wish to acknowledge the contributions of Drs Craig J. McClain and Alice for these conflicting findings might be that timing within the menstrual cycle was only considered in one study [40] Swim and statistical review by Dr Richard Kryscio.
